The Asia Pacific Single-use Filtration Assemblies Market should witness market growth of 18.3% CAGR during the forecast period (2022-2028).
Single-use assemblies have gained popularity throughout the global biopharmaceutical community. This expedites the manufacturing and medication development processes. The single-use filtrationassembly marketis expanding due to increased R&D spending by biopharmaceutical companies. In developed countries, there has been significant growth inthe release of new medications. Because of the rising use of single-use filtrationassemblies in development, testing, and research, scalingis anticipated to drive market expansion.
Life sciences companies are adamant about avoiding the pricey and time-consuming washing required when employing stainless steel. The faster growth of global biotech enterprises has created a growth environment where a novel, disposable technology becomes more significant. As the pharmaceutical business, suppliers, CDMOs, and producers fall behind on the payments for single-use components during the anticipated period, the market will expand more quickly.
Significant regional expansion is projected due to the high population density, increasing cancer occurrence, and a growing number of healthcare facilities. As a result of the various emerging players in the region, the production of biosimilars is expected to increase in countries like China and India. The region's high burden of healthcare spending is attributed to the region's geriatric population, which can increase revenue. Lack of medical infrastructure, particularly for cancer patients, and an increase in the number of cancer patients in this region are providing opportunities for private players to get involved, invest in government support, and provide patients with more medical services for their treatment. As a result, the government's continued efforts to expand the healthcare industry would support market expansion.
The China market dominated the Asia Pacific Single-use Filtration Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $633.9 million by 2028. The Japan market is estimated to grow a CAGR of 17.6% during (2022-2028). Additionally, The India market would experience a CAGR of 19% during (2022-2028).
Based on Application, the market is segmented into Bioprocessing/Biopharmaceuticals, Pharmaceuticals Manufacturing and Laboratory Use. Based on Type, the market is segmented into Membrane Filtration, Depth Filtration, Centrifugation and Others. Based on Membrane Filtration Type, the market is segmented into Tangential Flow Filtration (TFF) and Others. Based on Product, the market is segmented into Filters, Membranes, Cassettes, Cartridges, Manifold, Syringes and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Sartorius AG, Repligen Corporation, Merck Millipore (Merck Group), Danaher Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc., Cellab CDMO, Medela AG, and DrM, Dr. Mueller AG.
Single-use assemblies have gained popularity throughout the global biopharmaceutical community. This expedites the manufacturing and medication development processes. The single-use filtrationassembly marketis expanding due to increased R&D spending by biopharmaceutical companies. In developed countries, there has been significant growth inthe release of new medications. Because of the rising use of single-use filtrationassemblies in development, testing, and research, scalingis anticipated to drive market expansion.
Life sciences companies are adamant about avoiding the pricey and time-consuming washing required when employing stainless steel. The faster growth of global biotech enterprises has created a growth environment where a novel, disposable technology becomes more significant. As the pharmaceutical business, suppliers, CDMOs, and producers fall behind on the payments for single-use components during the anticipated period, the market will expand more quickly.
Significant regional expansion is projected due to the high population density, increasing cancer occurrence, and a growing number of healthcare facilities. As a result of the various emerging players in the region, the production of biosimilars is expected to increase in countries like China and India. The region's high burden of healthcare spending is attributed to the region's geriatric population, which can increase revenue. Lack of medical infrastructure, particularly for cancer patients, and an increase in the number of cancer patients in this region are providing opportunities for private players to get involved, invest in government support, and provide patients with more medical services for their treatment. As a result, the government's continued efforts to expand the healthcare industry would support market expansion.
The China market dominated the Asia Pacific Single-use Filtration Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $633.9 million by 2028. The Japan market is estimated to grow a CAGR of 17.6% during (2022-2028). Additionally, The India market would experience a CAGR of 19% during (2022-2028).
Based on Application, the market is segmented into Bioprocessing/Biopharmaceuticals, Pharmaceuticals Manufacturing and Laboratory Use. Based on Type, the market is segmented into Membrane Filtration, Depth Filtration, Centrifugation and Others. Based on Membrane Filtration Type, the market is segmented into Tangential Flow Filtration (TFF) and Others. Based on Product, the market is segmented into Filters, Membranes, Cassettes, Cartridges, Manifold, Syringes and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Sartorius AG, Repligen Corporation, Merck Millipore (Merck Group), Danaher Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc., Cellab CDMO, Medela AG, and DrM, Dr. Mueller AG.
Scope of the Study
By Application
- Bioprocessing/Biopharmaceuticals
- Pharmaceuticals Manufacturing
- Laboratory Use
By Type
- Membrane Filtration
- Tangential Flow Filtration (TFF)
- Others
- Depth Filtration
- Centrifugation
- Others
By Product
- Filters
- Membranes
- Cassettes
- Cartridges
- Manifold
- Syringes
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- 3M Company
- Sartorius AG
- Repligen Corporation
- Merck Millipore (Merck Group)
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Meissner Filtration Products, Inc.
- Cellab CDMO
- Medela AG
- DrM, Dr. Mueller AG
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Single-use Filtration Assemblies Market by Application
Chapter 5. Asia Pacific Single-use Filtration Assemblies Market by Type
Chapter 6. Asia Pacific Single-use Filtration Assemblies Market by Product
Chapter 7. Asia Pacific Single-use Filtration Assemblies Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- 3M Company
- Sartorius AG
- Repligen Corporation
- Merck Millipore (Merck Group)
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Meissner Filtration Products, Inc.
- Cellab CDMO
- Medela AG
- DrM, Dr. Mueller AG
Methodology
LOADING...